Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimuseluting bioresorbable scaffold and an everolimus-eluting metallic stent: Insights from the randomised ABSORB Japan trial

Yoshinobu Onuma, Yohei Sotomi, Hiroki Shiomi, Yukio Ozaki, Atsuro Namiki, Satoshi Yasuda, Takafumi Ueno, Kenji Ando, Jungo Furuya, Keiichi Igarashi, Ken Kozuma, Kengo Tanabe, Hajime Kusano, Richard Rapoza, Jeffrey J. Popma, Gregg W. Stone, Charles Simonton, Patrick W. Serruys, Takeshi Kimura